The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Hypertension 58
SANDOSTATIN LAR DEPOT Visual impairment 58
SANDOSTATIN LAR DEPOT Injection site swelling 57
SANDOSTATIN LAR DEPOT Rash 57
SANDOSTATIN Malaise 56
SANDOSTATIN LAR DEPOT Sleep disorder 56
SANDOSTATIN LAR DEPOT Blood glucose decreased 55
SANDOSTATIN LAR DEPOT Dehydration 55
SANDOSTATIN LAR DEPOT General physical health deterioration 55
SANDOSTATIN LAR DEPOT Discomfort 53
SANDOSTATIN LAR DEPOT Hot flush 53
SANDOSTATIN LAR DEPOT Pruritus 53
SANDOSTATIN LAR DEPOT Injection site erythema 52
SANDOSTATIN Malignant neoplasm progression 51
SANDOSTATIN LAR DEPOT Swelling 50
SANDOSTATIN LAR DEPOT Tremor 50
SANDOSTATIN LAR DEPOT Haemoglobin decreased 49
SANDOSTATIN LAR DEPOT Paraesthesia 49
SANDOSTATIN LAR DEPOT Alopecia 48
SANDOSTATIN LAR DEPOT Hypoaesthesia 48

Total Records: 2,045     Number of Pages: 103